<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/app/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.7"?>
<!-- generated-on="2026-06-24T19:27:03+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.7" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://www.pharma-marketing.com/chefkoch-and-yeswecancer-launch-cooking-hub-for-people-with-cancer/</loc><news:news><news:publication><news:name>Pharma-Marketing.com</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-24T13:11:54+00:00</news:publication_date><news:title>CHEFKOCH and yeswecan!cer launch cooking hub for people with cancer</news:title></news:news></url>
<url><loc>https://www.pharma-marketing.com/de/chefkoch-und-yeswecancer-starten-themenwelt-zum-kochen-mit-krebs/</loc><news:news><news:publication><news:name>Pharma-Marketing.com</news:name><news:language>de</news:language></news:publication><news:publication_date>2026-06-24T13:11:53+00:00</news:publication_date><news:title>CHEFKOCH und yeswecan!cer starten Themenwelt zum Kochen mit Krebs</news:title></news:news></url>
<url><loc>https://www.pharma-marketing.com/stada-to-acquire-orifarm-consumer-healthcare-portfolio/</loc><news:news><news:publication><news:name>Pharma-Marketing.com</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-24T12:08:18+00:00</news:publication_date><news:title>STADA to acquire Orifarm consumer healthcare portfolio</news:title></news:news></url>
<url><loc>https://www.pharma-marketing.com/de/stada-uebernimmt-consumer-healthcare-portfolio-von-orifarm/</loc><news:news><news:publication><news:name>Pharma-Marketing.com</news:name><news:language>de</news:language></news:publication><news:publication_date>2026-06-24T12:08:18+00:00</news:publication_date><news:title>STADA übernimmt Consumer-Healthcare-Portfolio von Orifarm</news:title></news:news></url>
<url><loc>https://www.pharma-marketing.com/cannes-lions-2026-announce-first-winners/</loc><news:news><news:publication><news:name>Pharma-Marketing.com</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-24T11:59:51+00:00</news:publication_date><news:title>Cannes Lions 2026 announce first winners</news:title></news:news></url>
<url><loc>https://www.pharma-marketing.com/de/cannes-lions-2026-geben-erste-gewinner-bekannt/</loc><news:news><news:publication><news:name>Pharma-Marketing.com</news:name><news:language>de</news:language></news:publication><news:publication_date>2026-06-24T11:59:51+00:00</news:publication_date><news:title>Cannes Lions 2026 geben erste Gewinner bekannt</news:title></news:news></url>
<url><loc>https://www.pharma-marketing.com/zeiss-rms-appoints-mediaplus-performance-for-global-media-management/</loc><news:news><news:publication><news:name>Pharma-Marketing.com</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-23T11:55:28+00:00</news:publication_date><news:title>ZEISS RMS appoints Mediaplus Performance for global media management</news:title></news:news></url>
<url><loc>https://www.pharma-marketing.com/de/zeiss-rms-beauftragt-mediaplus-performance-mit-globaler-media-steuerung/</loc><news:news><news:publication><news:name>Pharma-Marketing.com</news:name><news:language>de</news:language></news:publication><news:publication_date>2026-06-23T11:55:28+00:00</news:publication_date><news:title>ZEISS RMS beauftragt Mediaplus Performance mit globaler Media-Steuerung</news:title></news:news></url>
<url><loc>https://www.pharma-marketing.com/aurobindo-usa-receives-ftc-clearance-for-lannett-acquisition/</loc><news:news><news:publication><news:name>Pharma-Marketing.com</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-23T11:41:10+00:00</news:publication_date><news:title>Aurobindo USA receives FTC clearance for Lannett acquisition</news:title></news:news></url>
<url><loc>https://www.pharma-marketing.com/de/aurobindo-usa-erhaelt-ftc-freigabe-fuer-lannett-uebernahme/</loc><news:news><news:publication><news:name>Pharma-Marketing.com</news:name><news:language>de</news:language></news:publication><news:publication_date>2026-06-23T11:41:10+00:00</news:publication_date><news:title>Aurobindo USA erhält FTC-Freigabe für Lannett-Übernahme</news:title></news:news></url>
<url><loc>https://www.pharma-marketing.com/wefra-life-appoints-can-yildiz-as-chief-innovation-officer/</loc><news:news><news:publication><news:name>Pharma-Marketing.com</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-23T10:58:00+00:00</news:publication_date><news:title>WEFRA LIFE appoints Can Yildiz as Chief Innovation Officer</news:title></news:news></url>
<url><loc>https://www.pharma-marketing.com/de/wefra-life-ernennt-can-yildiz-zum-chief-innovation-officer/</loc><news:news><news:publication><news:name>Pharma-Marketing.com</news:name><news:language>de</news:language></news:publication><news:publication_date>2026-06-23T10:57:59+00:00</news:publication_date><news:title>WEFRA LIFE ernennt Can Yildiz zum Chief Innovation Officer</news:title></news:news></url>
<url><loc>https://www.pharma-marketing.com/abbvie-to-acquire-apogee-and-expand-immunology-pipeline/</loc><news:news><news:publication><news:name>Pharma-Marketing.com</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-23T10:14:10+00:00</news:publication_date><news:title>AbbVie to acquire Apogee and expand immunology pipeline</news:title></news:news></url>
<url><loc>https://www.pharma-marketing.com/de/abbvie-will-apogee-uebernehmen-und-immunologie-pipeline-ausbauen/</loc><news:news><news:publication><news:name>Pharma-Marketing.com</news:name><news:language>de</news:language></news:publication><news:publication_date>2026-06-23T10:14:09+00:00</news:publication_date><news:title>AbbVie will Apogee übernehmen und Immunologie-Pipeline ausbauen</news:title></news:news></url>
</urlset>
